Document is current
Any future updates will be listed below
-
Authors
van Zwieten, Anita http://orcid.org/0000-0003-4564-5825
Ryan, Elizabeth G.
Caldwell, Patrina
Howard, Kirsten
Tong, Allison
Craig, Jonathan C.
Alexander, Stephen I.
Howell, Martin
Teixeira-Pinto, Armando
Hawley, Carmel M.
Jesudason, Shilpanjali
Walker, Amanda
Mackie, Fiona
Kennedy, Sean E.
McTaggart, Steven
McCarthy, Hugh J.
Carter, Simon A.
Kim, Siah
Woodleigh, Reginald
Francis, Anna
Mallard, Alistair R.
Bernier-Jean, Amélie
Johnson, David W.
Hahn, Deirdre
Reidlinger, Donna
Pascoe, Elaine
Varghese, Julie
Kiriwandeniya, Charani
Vergara, Liza
Larkins, Nicholas
Macauley, Luke
Irving, Michelle
Khalid, Rabia
Guha, Chandana
Wong, Germaine
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (APP1170021, APP2014258, APP1106716, APP1092957, APP1092957, APP1194485)
National Health and Medical Research Council (APP1115259)
National Health and Medical Research Council (APP1168994)
National Health and Medical Research Council (APP1147657)
- License Information
-
More Information
Article History
Received: 28 June 2022
Accepted: 25 July 2022
First Online: 30 September 2022
Declarations
:
: Ethical approval has been obtained from the Sydney Children’s Hospital Network Human Research Ethics Committee (approval number: HREC/18/SCHN/325) and the University of Queensland Human Research Ethics Committee (clearance number 2019002528). Informed and voluntary written or verbal consent will be obtained from all participating caregivers (and assent from participating children where appropriate to their age), as detailed in the “consent process” section.
: Not applicable.
: RW is the Program Director of CanCare, a patient navigation programme for cancer patients run by the Prostate and Breast Cancer Foundation, Australia. DJ has received consultancy fees; research grants; speaker’s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care; consultancy fees from Astra Zeneca, Bayer and AWAK; speaker’s honoraria from ONO and BI & Lilly; and travel sponsorships from Ono and Amgen. The other authors declare that they have no competing interests.
